Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation

Abstract

Overall, our study unveils a novel regulatory mechanism of MHC-I on tumor cell surfaces by CEMIP-mediated internalization and degradation. Furthermore, targeting CEMIP provides an effective strategy for colorectal cancer immunotherapy.